<DOC>
	<DOCNO>NCT00180401</DOCNO>
	<brief_summary>The purpose study compare benefit cardiac resynchronization therapy ( CRT ) -therapy patient QRS-complex 120-150 m patient QRS-complex &gt; 150 m .</brief_summary>
	<brief_title>MODULA-Study : Modul 10 : Benefit CRT-Therapy CRT-Patients With QRS-Complex 120 - 150 Ms</brief_title>
	<detailed_description>The objective study compare benefit CRT-therapy patient QRS-complex 120-150 m patient QRS-complex &gt; 150 m within 12 month . A benefit defined change quality life change physical ability .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Patients cardiac resynchronization therapy defibrillator ( CRTD ) cardiac resynchronization therapy pacemaker ( CRTP ) system New York Heart Association ( NYHA ) III Ejection fraction ( EF ) 35 % Optimised medical therapy QRScomplex 120 m Patients CRTP atrial fibrillation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>